Diagonal chromatographic selection of cysteinyl peptides modified with benzoquinones by Dayon, L. & Girault, H. H.
ORIGINAL PAPER
Diagonal chromatographic selection of cysteinyl peptides
modified with benzoquinones
Loïc Dayon & Hubert H. Girault
Received: 20 May 2007 /Revised: 30 June 2007 /Accepted: 4 July 2007 /Published online: 16 August 2007
# Springer-Verlag 2007
Abstract The derivatization of cysteine-containing pep-
tides with benzoquinone compounds is rapid, quantitative
and specific in acidic media. The conversion of cysteines
into hydrophobic benzoquinone-adducted residues in pep-
tides is used here to alter the chromatographic properties of
cysteinyl peptides during liquid chromatography separation.
The benzoquinone derivatization is shown to allow the
accurate selection of cysteine-containing peptides of bovine
serum albumin tryptic digest by diagonal reversed-phase
chromatography, which consists of one primary and a series
of secondary identical liquid chromatographic separations,
before and after a cysteinyl-targeted modification of the
peptides by benzoquinone compounds.
Keywords COFRADIC™ . Labeling . Liquid
chromatography .Mass spectrometry . Proteomics . Tagging
Introduction
The identification and quantification of the proteins linked
to stimuli is the basis of proteomics. Disease and regulatory
events can, in this way, be recognized as the up- and down-
regulation of certain proteins. The modification of amino
acids has been used extensively for the relative quantification
of parallel cellular extracts. Isotopic tags, like the isotope-
coded affinity tag (ICAT) [1], have enabled the relative
quantification of proteins through mass spectrometry (MS).
Nevertheless, specific modifications of amino acids are often
performed for other reasons, namely the isolation of
compounds of interest and the detection of characteristic
features. These modification strategies, which aim at
reducing sample complexity and simplifying the analysis
of data, can be applied at the protein or at the proteolytic
peptide level.
Originally, diagonal chromatography was based on a
very simple observation. When a sample is chromato-
graphed in the x direction of a paper and dried, and then
rechromatographed in the perpendicular y direction using
the same elution conditions, the analytes appear in a
diagonal line on the 2-D chromatogram. Compounds that
are chemically modified between the two runs such that
their partition coefficients are affected will consequently
move from the diagonal and be specifically recognized. In
1966, Brown and Hartley described such a technique for
the isolation of cysteine peptides by diagonal paper
electrophoresis, by exposing the paper to vapors of
performic acid, converting cysteine to cysteic acid before
the reseparation [2]. Similar procedures were employed
later for the isolation of peptides carrying free amines [3],
and methionine- [4], histidine- [5] and tyrosine-containing
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peptides [6]. Vandekerckhove and coworkers have recently
applied the diagonal chromatography technique to high-
performance liquid chromatography (HPLC) for the tar-
geted proteomic isolation of analytes (reviews have been
recently published [7, 8]). Fractions collected from a first
reversed-phase (RP) HPLC run are chemically treated and
rechromatographed. The modified analytes then present a
different retention time (tR) during the second run.
Methionine-containing peptides and cysteine-containing
peptides were specifically isolated [9, 10]. In the same
way, Gevaert et al. demonstrated that this elegant method,
so-called combined fractional diagonal chromatography
(COFRADIC™), is able to reduce the complexity of
proteomic samples while retaining essential identification
information when targeting the N-terminal tryptic peptide
of proteins [11]. Regnier and coworkers investigated the
potential of the methods for the study of post-translational
modifications by enzymatic removal of the phosphorylation
modification before the second RP-HPLC [12]. This
approach was further used to analyze the phosphoproteome
of human HepG2 hepatocytes [13], and a procedure to map
N-glycosylation sites was presented [14].
The derivatization of cysteinyl peptides with 1,4-benzo-
quinone (1,4-BQ) (Scheme 1) was carried out to study the
specific fragmentation of benzoquinone-peptide adducts
during electrospray ionization (ESI) MS [15] by a pattern
recognition algorithm called SALSA (scoring algorithm for
spectral analysis) [16]. Moreover, the reaction of some
substituted 1,4-BQ compounds (noted BQ in general) with
cysteine was shown to be rapid and selective for the thiol
group of L-cysteine when performed in an acidic medium
[17]. An evaluation of the use of BQ for the modification
and isolation of cysteine peptides by diagonal chromatog-
raphy is proposed herein. The derivatization is easily
performed between the first and second RP-HPLC runs,
taking advantage of the fact that the derivatization reaction
can be performed in acidic conditions. Substituted BQs,
with increasing hydrophobicities, are evaluated in terms of
their selectivity, their reactivity as well as the retention time
shift they induce on targeted cysteinyl peptides. The
cysteine modification with 1,4-BQ compounds is then used
for the diagonal reversed-phase chromatographic selection
of the cysteinyl peptides of a bovine serum albumin (BSA)
tryptic digest.
Materials and methods
Chemicals
1,4-Benzoquinone (1,4-BQ, ≥98%), methyl-1,4-benzoqui-
none (Me-1,4-BQ, ≥98%), 2,5-dimethyl-1,4-benzoquinone
(2,5-diMe-1,4-BQ, ≥98%) and L-cysteine (>99.5%) were
from Fluka (Büchs, Switzerland). Synthetic peptide
AIKCTKF (>70%) was prepared by Catherine Servis at
the Institut de Biochimie (Faculté de Médecine, Epalinges,
Switzerland) and was further purified by semi-preparative
RP-HPLC. Bovine serum albumin (BSA, minimum 98%)
and myoglobin from horse heart (>90%) were purchased
from Sigma (St. Louis, MO, USA). Sequencing grade
modified trypsin was from Promega (Madison, WI, USA).
Methanol (>99.8%, Riedel-de Haën, Seelze, Germany),
trifluoroacetic acid (TFA, 99%, Merck, Darmstadt, Ger-
many), formic acid (FA, 98–100%, Merck) and acetic acid
(>99.5%, Fluka) were used without any further purification.
Water (UV-HPLC) and acetonitrile (HPLC-gradient grade)
were bought from Panreac Quimica S.A. (Barcelona, Spain).
Benzoquinone reagent evaluation
The RP-HPLC separations were performed with an Alli-
ance 2690 system from Waters (Milford, MA, USA)
comprising a 996 photodiode array detector for ultraviolet
(UV) detection.
To evaluate the potential of cysteinyl peptide derivatiza-
tion via BQ tags in diagonal chromatography, the peptide
AIKCTKF was first purified by semipreparative RP-HPLC.
The peptide was collected and divided into two samples. The
first sample was directly reinjected into the RP-HPLC. The
second sample was modified with BQ through the addition
of 1% (V/V) of BQ reagents at 100 mM in CH3CN (large
excess), where all of the BQs under study were found to be
stable for at least one hour (data obtained from RP-HPLC
survey not shown). The reaction was performed at room
temperature for 60 min. One hundred microliters of the
modified mixture were rechromatographed. The unmodi-
fied and modified AIKCTKF were analyzed using the same
Nucleosil 100-5 C18 column from Macherey-Nagel
(Düren, Germany). The separation was run for 60 min
using a gradient of H2O/TFA 99.88%/0.12% (solvent A)
and CH3CN (solvent B). The gradient was run as follows:
O
O
OH
OH
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RSH
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+
Scheme 1 Reaction of cysteine moieties (RSH) with 1,4-BQ
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0–3 min 100% A, then to 62% A and 38% B at 43 min,
43% A and 57% B at 50 min, and 20% A and 80% B at
60 min at a flow rate of 1 mL min−1. Eluted compounds
were collected and were analyzed by ESI–MS without fur-
ther sample preparation using a Finnigan LCQ duo ion trap
mass spectrometer (Thermo Electron, San José, CA, USA).
BSA digestion and isolation of proteolytic cysteinyl
peptides by diagonal capillary LC ESI–MS
Two milligrams of BSA were dissolved in 2 mL of
ammonium bicarbonate solution (5 mM, pH8). 1.23 mg
of DTT (to give a final concentration of 4 mM) and 20 μg
of trypsin (protein ratio of 1:100 w:w) were added. The
digestion was run at 37 °C for 4 h. Five micrograms of the
BSA digest were separated on an LC Packings Ultimate™
(Dionex, Olten, Switzerland) capillary RP-HPLC system
equipped with a UV detector. An LC Packings C18
PepMap 100 column (15 cm, 3 μm, 100 Å) was used.
The separation was run for 60 min using a gradient of H2O/
CH3CN/FA 98%/2%/0.1% (solvent C) and H2O/CH3CN/
FA 20%/80%/0.085% (solvent D). The gradient was run as
follows: 0–3 min 100% C, then to 45% C and 55% D at
43 min, 30% C and 70% D at 50 min, and 100% D at
60 min at a flow rate of 4 μL min−1. Fractions of 2 min
each (i.e., 8 μL) were collected between 14 and 38 min of
the gradient and pooled when separated by 12 min. The
pooled fractions of 16 μL were treated by addition of 9 μL
of BQ at 14 mM in CH3CN (final reaction mixture
concentration of BQ of 5 mM), and the reaction was
performed for 60 min at room temperature. The fractions
were dried with a speed vacuum system (Martin Christ,
Osterode am Harz, Germany) to get rid of CH3CN, and
then dissolved in 15 μL of solvent C. Ten microliters were
injected and separated during an identical second LC run
and analyzed on-line by ESI–MS (LCQ duo ion trap) with a
sheath liquid of 1 μL min−1 of solvent D, a N2 sheath gas
flow of 40 (arbitrary units), and a spray voltage of 4.5 kV.
A classical ESI source was used. All mass spectra were
acquired in positive ionization mode with a m/z scan range
of 500–2000 Th. The heated capillary was kept at 200 °C.
The ion transmission parameters were tuned automatically
on a standard peptide. The mass accuracy was found to be
between 200 and 300 ppm.
Protein identification
For each ESI–MS experiment, m/z values were manually
picked when the peaks showed good signal-to-noise ratios
and their relative abundances were superior to 20% on the
mass spectra. No tandem MS (MS/MS) experiments were
performed because of license limitations that exclude
extraction of the MS/MS data via SEQUEST. The obtained
m/z peak lists were converted to an M peak lists, according
to M ¼ m=zð Þz zmp, where mp is the mass of the proton
(see the “Electronic supplementary material,” Figure S1).
The M peak lists were then submitted to peptide mass
fingerprinting (PMF) for identification of the protein using
Aldente database search software (http://www.expasy.org/
tools/aldente/). The search was performed in UniProtKB/
Swiss-Prot and the main search parameters were Chordata
for the taxonomy, monoisotopic for the resolution, [M] for
the ion mode, and 0.4 Da, 400 ppm and 75 ppm
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Fig. 1 Reversed-phase chromatograms at 214 nm of AIKCTKF (a),
AIKCTKF modified with 1,4-BQ (b), and 2,5-diMe-1,4-BQ (c). The
benzoquinone and hydroquinone compounds are labeled as BQ and HQ
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respectively for spectrometer shift, slop and internal error.
Methionine oxidation was considered to be a variable
modification, and the different BQ modifications were
defined and set as fixed modifications. When several peaks
presented a difference in mass that was lower than the
spectrometer internal error, the mass values were replaced
by their average.
Results and discussion
Evaluation of the use of benzoquinone reagents
to alter the hydrophobic properties of a model peptide
The tagging of model peptides by BQ was carried out in
order to modify their hydrophobicity properties. In order of
increasing hydrophobicity, 1,4-benzoquinone (1,4-BQ),
methyl-1,4-benzoquinone (Me-1,4-BQ), and 2,5-dimethyl-
1,4-benzoquinone (2,5-diMe-1,4-BQ) were employed to
observe their influence (via chemical modification) on the
peptide retention time (tR).
The synthetic peptide AIKCTKF was chromatographed
using a gradient of 60 min optimized for the separation of
tryptic peptides (see “Materials and methods”). The eluted
peptide was collected, treated with a BQ reagent and
rechromatographed. The chromatograms obtained with and
without derivatization are depicted in Fig. 1. The addition
of the thiol onto Me-1,4-BQ has been previously shown to
occur at different sites on the BQ core [17]. As a
consequence, isobaric adducts were separated during LC
and identified by ESI–MS. Me-1,4-BQ modification is thus
not convenient when a separation step follows. When using
1,4-BQ as modifier, one product was quantitatively formed.
Nevertheless, the adducted peptide was found to have a
difference in mass of 2 Da from the expected product
(Fig. 1b and Scheme 1). A control experiment involving the
reaction of this labeled peptide with L-cysteine revealed that
the addition of L-cysteine occurred on the labeled peptide
(data not shown). This shows that the quinone tag bound to
the peptide is in its oxidized form. As observed in a
previous work [18], the large excess of BQ used during the
labeling reaction induces the reoxidation of the hydroqui-
none (HQ) label. The BQ-modified peptide (which is 2 Da
lighter) is formed, as shown by the equilibrium in Scheme 2
[19]. The HQ formed in this reaction also appears in the
chromatogram of Fig. 1b. When 2,5-diMe-1,4-BQ was used
as the tagging reagent, most of the adducts obtained were
the label-oxidized ones, although non-label-oxidized ones
were also attained, as illustrated in Fig. 1c. The oxidation
by the excess reagent is less efficient than with 1,4-BQ. The
reaction was found to be total in terms of the labeling
efficiency. Only trace amounts of the unmodified peptide
can be seen on the chromatograms.
The unmodified AIKCTKF was detected at tR1=
27.2 min. After modification, the major adduct formed
came out at tR2=30.6 min and 34.0 min when modified
with 1,4-BQ and 2,5-diMe-1,4-BQ, respectively. Due to its
higher hydrophobicity, the tR shift (ΔtR) is larger for the
latter. Respective ΔtR values of 3.4 and 6.8 min show that
the BQ tags can be potentially used for diagonal chroma-
tography. Indeed, the minimum ΔtR of 3.4 min obtained
with 1,4-BQ is theoretically sufficient for use with a
sampling collection time of 1 min for the first dimension
[12]. The fraction window from the first dimension of
diagonal chromatography will be much wider and will
show multiple analytes in the second RP-HPLC run. The
modified peptides must have sufficient ΔtR values to move
out from the overlap region so that they can be distin-
guished from false positives (i.e., peptides with shorter or
longer retention times whose peak leading or trailing edges
are collected in the fraction) moving out from the initial
time interval. Studies with other model cysteinyl peptides
were carried out and these confirmed the scale of the tR
shift induced by the BQ modification (data not shown).
OH
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O
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+
1,4-BQ 1,4-HQ
Scheme 2 Excess 1,4-BQ induces reoxidation of the tagged product
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Selection of the cysteinyl peptides from bovine serum
albumin digest by diagonal liquid chromatography
using 1,4-benzoquinone or 2,5-dimethyl-1,4-benzoquinone
The reaction between the peptides and the BQ compounds
may vary when implemented on a mixture of peptides. A
tryptic digest of BSA was tested in this diagonal chromato-
graphic approach for the selection of cysteinyl peptides.
BSA, which contains 35 cysteine residues and provides 25
cysteinyl peptides when digested by trypsin, is an excellent
candidate for this proof of principle.
BSA digest was fractionated during a first capillary
liquid chromatography dimension at a flow rate of
4 μL min−1. Twelve fractions of 2 min (i.e., 8 μL fractions)
were collected as shown in Fig. 2. Fractions spaced by
12 min were combined and the six obtained fractions were
derivatized by BQ, either 1,4-BQ or 2,5-di-1,4-MeBQ.
After the reaction, the fractions were dried under vacuum to
get rid of CH3CN. Each fraction was then rechromato-
graphed using the same separation conditions, and analyzed
on-line by ESI–MS. As illustrated by Figs. 3 and 4, some
peptides move out from the initial fraction time window.
MS analyses confirmed that the retention shifts of the
peptides result from the reactions of their cysteine(s) with
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Fig. 3 Reversed-phase chromatogram at 214 nm of collected pooled
fractions 4 and 10 of BSA tryptic peptides modified with 1,4-BQ (a)
and a relative base peak chromatogram obtained by ESI–MS (b). The
masses of identified modified cysteinyl peptides are underlined
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Fig. 2 Reversed-phase chromatogram at 214 nm of BSA digest (a)
and a relative base peak chromatogram obtained by ESI–MS (b)
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Fig. 4 Reversed-phase chromatogram at 214 nm of collected pooled
fractions 4 and 10 of BSA tryptic peptides modified with 2,5-diMe-1,
4-BQ (a) and a relative base peak chromatogram obtained by ESI–MS
(b). The masses of identified modified cysteinyl peptides are underlined
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hydrophobic BQ compounds (Table 1). The m/z peak list,
generated by the LC ESI ion trap MS analysis of the treated
fractions, was converted to a M peak list (see “Electronic
supplementary material,” Figure S1), and was submitted to
peptide mass fingerprinting (PMF) to identify the protein
using Aldente database search software (http://www.expasy.
org/tools/aldente/). Using this software, it is possible to
implement specific modifications, and a mass of 108 and
136 Da (add C6H5O2, suppress H and add C8H9O2,
suppress H were respectively specified in the Aldente
Table 1 Identification of BSA cysteinyl peptides by diagonal chromatography using 1,4-BQ and 2,5-diMe-1,4-BQ
Sequence (start–end)a Cysteine content (m/z)b/
Th
Diagonal chromatography with BQ modification
(m/z)b/Th ΔtR
c/min (fractiond)
1,4-BQ 2,5-diMe-1,4-
BQ
1,4-BQ 2,5-diMe-1,4-
BQ
TCVADESHAGCEK (76–88) 2 1349.60,
675.40
– 1621.53, 811.53 – 7.0 (1)
SHCIAEVEK (310–318) 1 1015.47,
508.40
1123.40,
562.27
1151.40 3.6 (1) 4.4 (1)
QNCDQFEK (413–420) 1 1011.47 1119.33 1147.33 2.7 (2) 5.0 (2)
LCVLHEK (483–489) 1 841.47 949.40 977.40 2.4 (2) 4.4 (2)
NECFLSHK (123–130) 1 977.53 1085.40 1113.33 1.9 (2) 4.2 (2)
ECCDKPLLEK (300–309) 2 1177.53,
589.47
1393.40 – 3.1 (2) –
LKECCDKPLLEK (298–309) 2 1418.67,
710.00
1634.40, 818.33 1690.47, 845.93,
564.40
2.5 (2) 5.9 (3)
CCTESLVNR (499–507) 2 1024.53
YICDNQDTISSK (286–297) 1 1386.60 1494.47 1522.33 2.0 (3) 5.6 (3&4)
GACLLPK (198–204) 1 701.40 809.33 837.40 3.0 (3&4) 5.9 (4)
NECFLSHKDDSPDLPK (123–138) 1 1844.80 1952.60,
976.93
1981.60, 991.40 1.5 (4) 3.3 (4)
CCADDKEACFAVEGPK (581–597) 3 1756.60,
879.00
– – – –
EACFAVEGPK (588–597) 1 1050.53 1158.27 1186.47 1.9 (4) 4.9 (5)
ETYGDMADCCEK (106–117) 2 1364.47 – 1636.33 – 8.5 (5)
DDPHACYSTVFDK (387–399) 1 1497.53 1605.53,
803.33
1633.47, 817.33 1.9 (5) 4.4 (5)
ECCHGDLLECADDR (267–280) 3 – 951.87 1986.60, 993.80 (5) (5)
EYEATLEECCAK (375–386) 2 1388.60 – – – –
ECCHGDLLECADDRADLAK
(267–285)
3 1039.07 1201.47 1243.40 2.5 (5) 7.2 (5)
RPCFSALTPDETYVPK (508–523) 1 912.53 1932.80,
966.93
980.87 1.0 (6) 2.5 (6)
LKPDPNTLCDEFK (139–151) 1 1519.67 1627.47 1655.47, 828.40 1.5 (6) 4.1 (6)
YNGVFQECCQAEDK (184–197) 2 1633.67 1849.53 1906.40 2.1 (6) 7.8 (6)
SLHTLFGDELCK (89–100) 1 1362.67,
681.93
1470.53,
736.40
1498.47, 749.27 1.7 (6&7) 2.7 (7)
LFTFHADICTLPDTEK (529–544) 1 1850.80,
926.07
1957.53,
979.87
1986.60, 994.47 1.9 (7) 3.1 (8)
DAIPENLPPLTADFAEDKDVCK
(319–340)
1 1201.67 1255.47 1269.47 0.4 (8) 1.7 (8)
QEPERNECFLSHK (118–130) 1 1616.53 – – – –
MPCTEDYLSLILNR (469–482) 1 1667.80,
834.53
1775.63,
888.40
1803.54, 902.40 0.2 (10) 1.8 (11)
A reference one-dimensional LC ESI–MS experiment was carried out to compare the identified peptide masses with those obtained after
derivatization with BQ, and to determine the ΔtR induced by the modification.
a Sequence of cysteinyl identified peptides. b m/z of identified cysteinyl peptides. c ΔtR obtained from a reference one-dimensional LC ESI–MS
experiment; ΔtR were corrected according to the experimental tR values of non-cysteinyl peptides, which should maintain their retention times
between chromatographic runs. d Fraction in which the peptide was found.
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modification frame) was added to the cysteine residues,
corresponding respectively to 1,4-BQ and 2,5-diMe-1,4-BQ
addition. The robustness of the protocol in terms of the
chemical reactivity of the tagging was assessed. Identical
lists of matched peptide masses we obtained from the BSA
identification whether the cysteine modification was de-
fined as fixed or as variable. It can be concluded that the
BQ modification is therefore fixed, quantitative and specific,
because non-cysteinyl peptides retained their masses as well
as their tR values. As displayed in the chromatograms in
Figs. 3 and 4 and in Figs. S2–S5 (see “Electronic
supplementary material”), only the cysteine-containing
peptides present significant retention time shifts. Moreover,
no significant reoxidation of the adducted peptides by the
excess BQ was observed. When fixed mass additions of
106 and 134 Da (reoxidized labels) were implemented for
1,4-BQ and 2,5-diMe-1,4-BQ modifications, the PMF
suggested only one and five peptides containing cysteine,
respectively, whereas 20 and 21 were indicated when the
reoxidation was ignored (Table 1). Verification of the mass
spectral data indicated that the peptides undergoing reox-
idation of the attached HQ are low-intensity (1/3 of their
unoxidized counterparts). Reducing the excess of BQ for
labeling or adding HQ after BQ labeling to reverse the
equilibrium depicted in Scheme 2 (data not shown) are
possible ways of avoiding uncontrolled reoxidation.
As a control, the same BSA digest was directly subjected
to LC ESI–MS. The BSA identification score and protein
coverage obtained with Aldente were similar to the ones
obtained from the diagonal chromatographic experiments
(scores of 1334, 1065 and 1015 and coverages of 74, 67
and 68%, respectively, for the single-run analysis and for
diagonal experiments with 1,4-BQ and 2,5-DiMe-1,4-BQ).
Despite the decrease in the global MS signal for peptides
present in two consecutive fractions and the loss of analytes
when rechromatographing the fractions, the diagonal
chromatographic technique presents many advantages.
Interestingly, several cysteinyl peptides that were not
identified in the LC ESI–MS analysis were recovered when
the diagonal approach was used (Table 1). As a fraction
undergoes an alteration of its cysteinyl peptides, its
chromatographic time window enlarges during the second
LC run. Coeluted peptide overlaps and related signal
suppression during ESI–MS can be avoided, especially
since the increased hydrophobic properties of the peptides
may help their ESI [20]. Another advantage is the increase
in the number of MS/MS measurements that can be
performed on the sample. Finally, because cysteine is a
rare amino acid, the technique could be of great value when
it is necessary to simplify complex peptide mixtures, since
it focuses the analysis on cysteinyl peptides only and gains
valuable information on the presence of cysteine in peptides
for protein identification [21].
The 2-D representation shown in Fig. 5 is convenient for
evaluating the efficiency of the diagonal chromatography
experiment. Log(tR2) values of the identified and diagonally
chromatographed peptides are given as a function of their
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Fig. 5 2-D representations of the diagonal chromatographic separa-
tion of BSA tryptic peptides with 1,4-BQ (a) and 2,5-diMe-1,4-BQ
(b). A log scale was employed to represent tR2 as a function of tR1.
Cysteinyl peptides can be distinguished because the hydrophobic
properties they acquire before the second RP-HPLC run make them
shift from the diagonal. Peptides containing one, two and three
cysteines appear in red, blue, and green, respectively. Non-cysteinyl
peptides are represented in black. Trend lines are plotted for peptides
containing one cysteine (discontinuous red lines)
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log(tR1) values in the single-run LC ESI–MS experiment.
Modified peptides are located above the diagonal as their
Gibbs energies of partition from the aqueous solution to the
hydrophobic stationary phase are larger, while unmodified
peptides are positioned on it. As discussed previously, the
retention shifts are larger for peptides modified with the
most hydrophobic compounds, in the ranges of 0.2–3.6 and
1.7–8.5 min for 1,4-BQ and 2,5-diMe-1,4-BQ, respectively
(Table 1). 2,5-DiMe-1,4-BQ is therefore the most suitable
tagging reagent for use in the selection of cysteinyl peptides
by COFRADIC™. The ΔtR induced by the modification
depends on the hydrophobicities and lengths of the peptides
as well as the number of cysteines in their sequences.
Assuming a linear relationship for Gibbs energy, as for the
Kovats indices in gas chromatography for example, the
Gibbs energy of partition for the modified peptide should
obey the following equation:
ΔGop P Tnð Þ ¼ ΔGop Pð Þ þ nΔGop Tð Þ
where ΔGop P Tnð Þ, ΔGop Pð Þ and ΔGop Tð Þ represent the
Gibbs energies of partition of the tagged peptide, the
peptide, and the tag, respectively. This equation therefore
predicts that Δln(tR) should be proportional to the number
of tags per peptide n. From Fig. 5, it is clear that Δln(tR)
does not follow this prediction based on a direct Gibbs
linear relationship. Indeed, the longer the peptide, i.e., the
greater the retention time, the smaller the value of Δln(tR).
These data show that intramolecular hydrogen bonding and
peptide folding for long peptides decrease the Δln(tR) value
and prevent the observation of a direct relationship between
Δln(tR) and the number of tags per peptide.
Conclusion
Diagonal chromatography is a convenient strategy for
simplifying a complex protein mixture. By changing the
alteration reaction, different classes of peptides can be
differentiated and analyzed [7]. A simple method for the
selection of cysteinyl peptides was developed based on
cysteine modification with benzoquinone compounds. The
derivatization protocol allows quantitative and selective
processing in acidic media, and is perfectly adapted for
handling between two RP-HPLC runs. It was demonstrated
that the use of 2,5-dimethyl-1,4-benzoquinone provides
sufficient retention time shifts (1.7–8.5 min depending on
the hydrophobicity of the peptide and on its cysteine
content). The diagonal chromatographic method presented
herein has been shown to be efficient for the selection of
the cysteinyl tryptic peptides of BSA, and would enable the
simplification of tryptic samples as well as a reduction in
the undersampling induced by the coelution of some
peptides [22].
As a perspective, we have currently been investigating
the potential of modifications of specific amino acids to
shift the isoelectric point (pI) of peptides. The recently
developed off-gel™ electrophoresis (OGE) fractionation
technique could be used for this purpose [23, 24]. As OGE
fractionates biomolecules in solution according to their pI,
the technique could easily be used for diagonal fraction-
ation, on the condition that sufficient pI shifts can be
induced on the targeted peptides [25].
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